ovarian cancer

(Oregon Health & Science University) A constellation of defective proteins suspected in causing a malfunction in the body's ability to repair its own DNA could be the link scientists need to prove a new class of drugs will be effective in treating a broad range of ovarian cancer patients, an Oregon Health & Science University Knight Cancer Institute study found.

(Mayo Clinic) The use of two drugs never tried in combination before in ovarian cancer resulted in a 70 percent destruction of cancer cells already resistant to commonly used chemotherapy agents, say researchers at Mayo Clinic in Florida.

(University of Guelph) A potential breakthrough in treating late-stage ovarian cancer has come from University of Guelph researchers who have discovered a peptide that shrinks advanced tumors and improves survival rates for this deadly but often undetected disease.

A "fatty apron" in the abdomen help fuel the spread of ovarian cancer, research suggests.

Women who undergo ovarian stimulation as part of IVF (in vitro fertilization) treatment may be more likely to develop "borderline" ovarian tumors, but not invasive ovarian tumors, later in life, Dutch researchers report.

Women who take the Pill for 10 years almost halve their risk of ovarian cancer, according to a study.

(Terry Fox Research Institute) Women throughout the world will benefit from a new, pan-Canadian Terry Fox Research Institute initiative that aims to change the way in which ovarian cancer is diagnosed and managed.

Through TFRI leading ovarian cancer researchers and clinicians across Canada have joined forces to develop a "made-in-Canada" solution to this global clinical problem facing cancer doctors.

(Technische Universitaet Muenchen) Scientists from Technische Universitaet Muenchen, Helmholtz Zentrum Muenchen and University of Groningen have now deployed a new imaging technology using laser light to detect cancer based on molecular signatures, leading to the localization of even small cancer cell nests that surgeons might otherwise overlook during surgery.

The technique has now been successfully tested on nine patients diagnosed with ovarian cancer. There are plans to apply this imaging concept also to minimally invasive and endoscopic procedures.

A chemical in the blood could one day help doctors spot early signs of ovarian cancer, research suggests.

(Wiley-Blackwell) A new analysis has found that many doctors report that they do not appropriately offer breast and ovarian cancer counseling and testing services to their female patients.

Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study indicates that efforts are needed to encourage these services for high-risk women and discourage them for average-risk women.